$17.7MRound, 16 September 2025
Funds speed the Phase 2b trial in basal cell carcinoma and strengthen the team.
- Amount
- $17.7M
- Announced
- 16 September 2025
- Lead
- Buenavista Equity Partners
- Other investors
- Columbus Venture Partners
- Use of funds
- Funds speed the Phase 2b trial in basal cell carcinoma and strengthen the team.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Highlight Therapeutics raises €15M (Undisclosed) - Tech.eu Funding Explorer bolsamania.com
Highlight Therapeutics raises €15M (Undisclosed) - Tech.eu Funding Explorer funding.tech.eu